Early DETECTion and integrated management of TuBerculosis in europe: E-DETECT TB Professor Ibrahim Abubakar Director, Institute for Global Health University.

Slides:



Advertisements
Similar presentations
Stop TB Strategy Planning Frameworks Mukund Uplekar TB Strategy, Operations and Health Systems, Stop TB Department, WHO.
Advertisements

Building an EU consensus for minimum quality standards June 2011, Brussels | WHO: Normative guidance on and quality standards in drug demand reduction.
Health impact assessment explained
¨ Dr Alain Garcia General Secretary of the Rare Diseases National Plan The second National Plan for Rare Diseases in France
Renewing Health Canada’s strategy against TB for First Nations on-reserve Provincial Primary Care Tuberculosis Education Day October 28, 2011 Presented.
M. Samarkos TUBERCULOSIS IN GREECE. INTRODUCTION.
European Partnership for Action Against Cancer (EPAAC)
Bill Edgar (Dundee University) Matt Harrison (RIS) Volker Busch-Geertsema (GISS) European Commission MPHASIS Mutual Progress on Homelessness through Advancing.
THE EUROCHIP PROJECTS Health Indicators for Health Indicators for Monitoring Cancer in Europe
Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009.
Identification of critical success factors for implementing NLLS, through collaboration and exchange of expertise IDENTIFY LLP-2008-RO-KA1-KA1NLLS.
Comprehensive M&E Systems
GLOBAL TB PROGRAMME Systematic screening for active TB – from guideline to operational manual A TBCARE 1 (USAID) project by ATS, FHI360, KNCV, MSH, TBREACH.
Concept Note on HIV Mongolia Process and key components of Funding Request to Global Fund.
EQUI - TB Knowledge Programme Quality Assured TB Care for Poor People in Resource Constrained settings 2001 – 2006 Purpose: To promote implementation of.
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
HIV Patient ART Monitoring Meeting: International Conference Centre, Geneva March 2004 Defining the variables.
THANK YOU!. Regional Adviser, Noncommunicable Diseases, WHO/EMRO Dr Ibtihal Fadhil.
Operational Research in the 21 st Century. International Union Against Tuberculosis and Lung Disease (The Union) World’s oldest humanitarian organization.
Jennifer Hillebrand, „Rehabilitation of Drug Addicted Persons: Experience of Lithuania and European Countries”, 18 October 2007 Improving drug treatment.
Overview of operational research in MSF Myriam Henkens, MD, MPH International Medical Coordinator MSF London 1st of June, 2006.
Ingenious-science.eu ECB National Needs Analysis Workshop – Israel Charmaine Kerr ECB Project Coordination.
Studying Quality and Safety in European Hospitals - QUASER 9 th June, 2010 Prof Naomi Fulop Dr. Janet Anderson NIHR King’s Patient Safety and Service Quality.
The Research and Development Goals of the Global Plan to Stop TB Marcos Espinal Executive Secretary.
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
Strengthening global awareness in the local communities - Kolping 2020 Strategy.
Towards a European network for digital preservation Ideas for a proposal Mariella Guercio, University of Urbino.
MESH UK Workshop 19 October 2006 Introduction Dr Paul Gilliland Marine Policy Adviser and MESH Partner Lead Natural England.
World Bank Project China Fidelis Demonstration projects Mobilising funding for TB & Poverty Are there effective, implementable strategies?
1 Women Entrepreneurs in Rural Tourism Evaluation Indicators Bristol, November 2010 RG EVANS ASSOCIATES November 2010.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
The European Innovation Partnership for asthma: an opportunity for change Samantha Walker PhD, Asthma UK Project Coordinator, EARIP (European Asthma Research.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
BMH CLINICAL GUIDELINES IN EUROPE. OUTLINE Background to the project Objectives The AGREE Instrument: validation process and results Outcomes.
DETERMINE Working document # 4 'Economic arguments for addressing social determinants of health inequalities' December 2009 Owen Metcalfe & Teresa Lavin.
Community-centered Clinical Services: Case Studies and Lessons Learned from Implementing Key Population Programs in India Anjana Das STI Capacity Building.
1 DEWG meeting October 2009 Human Resource Development for TB Control (HRD-TB) Sub Group within the DEWG of the Stop TB Partnership. Wanda Walton.
The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Dr Rochelle Adams ACC Project Manager On behalf of the ACC team AWACC November 2015 Health systems Strengthening for Success and Sustainability.
RARE BEST PRACTICES COURSE ROMA (Feb ) Euro-HSP Madrid 2015 May 30 Jean Bénard May 31, GA 2015 Madrid.
Good Practice in the Field of Health Promotion and Primary Prevention: Concept, Methods and Outputs Thomas Kunkel, MD, M.Sc. JA CHRODIS Work Package 5.
1 1  key values social justice, empowerment, solidarity, activism, independence and balance (e.g. between service delivery and advocacy)  NGO created.
Technology Needs Assessments under GEF Enabling Activities “Top Ups” UNFCCC/UNDP Expert Meeting on Methodologies for Technology Needs Assessments
GLOBAL TB PROGRAMME Systematic screening for active TB – operational manual and tool to help prioritization Wolfheze 2015 Knut Lönnroth, Global TB Programme.
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
Advisory Forum November 28th-29th 2005 HIV, AIDS and Other Sexually Transmitted and Blood Borne Infections Prof Angus Nicoll SNE - HIV & STI Co-ordinator.
Małgorzata Lublińska Ministry of Regional Development in Poland.
Health Technology Assessment Methodology, an EUnetHTA View Basics for the Assessment in EU Countries PharmDr. Martin Visnansky, MBA, PhD., MSc. (HTA) HTA.
A look into current and future trends in national policies for eHealth and Innovation in the WHO European Region Clayton Hamilton, eHealth and Innovation.
European network for Health Technology Assessment | JA | EUnetHTA European network for Health Technology Assessment THL Info.
Cochrane Agenda and Priority Setting Methods Group (CAPSMG)
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
TB and the right to health Nelson Otwoma National Coordinator- NEPHAK.
Overview of guidance/frameworks
MANAGE - CARE Prof. Dr. med. habil. Peter Schwarz
Prisons and TB in Europe
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Committee Task Statement (1)
INTEGRATE satellite symposium AIDS 2018, Amsterdam, the Netherlands
Knowledge gaps in formulating TB Control Policies for Prisons
SRH & HIV Linkages Agenda
HEPCARE EUROPE Lessons learned on HCV testing and treatment through outreach to the community and linkage-to-care Dr. Jack Lambert Dublin │ London │
Prison health in the WHO European Region
The STOP TB Strategy – 2009 VISION: A TB-free world
WP 4: Outreach for early diagnosis
Getting Knowledge into Action for Healthcare Quality
Presentation transcript:

Early DETECTion and integrated management of TuBerculosis in europe: E-DETECT TB Professor Ibrahim Abubakar Director, Institute for Global Health University College London

Outline 1.Background and context 2.Objectives 3.Proposed methods 4.Expected outcomes 5.Tools planned 6.Partnership

1. Background: TB Rates in the EU High burden of TB in the EU: the 30 EU/EEA countries reported cases of tuberculosis (TB) in 2013, a rate of 12.7 per 100, % was multidrug resistant (MDR) TB In many settings, TB disproportionately affects the vulnerable groups

2. Objectives 1.To ensure early diagnosis in vulnerable populations- defined as homeless individuals, Roma, those with a history of drug use within the community, and prisoners- in two high incidence European countries (Romania and Bulgaria). 2.To strengthen care integration using an outreach strategy within the same vulnerable populations in Romania

2. Objectives 3.To evaluate approaches for migrant TB detection and improve European cross-border management by: –early detection and care integration in individuals arriving via the Mediterranean sea in Italy using innovative molecular testing at immigration reception centres and novel latent TB tests. –collating, analysing and evaluating multi country data on TB in migrants to low incidence countries to inform effective strategies for early diagnosis of active and latent TB in low incidence EU countries. –ensuring cross-border transfer of information and referral of patients 4.To support the development of action plans in member states by adapting best practice approaches to support the use of these measures across other EU member states

WP 4 Outreach: Community and Prisons Screening WP 5 Migrants: Screening in Italy WP 6 Migrants: Learning from database integration Evaluation : WP 3 Coordination : WP 1 Dissemination : WP 2 WP 7: Strengthening national programmes 3. Methods: Work Packages

3. Proposed Methods: Outreach (WP4) Early diagnosis: screening at one-stop “shop” Mobile X-Ray Unit Teleradiology + CAD GeneXpert Omni Integrated care: Accompanied referral, social support to vulnerable groups, peer support Free Treatment by the national TB programme for cases including MDR-TB Monitoring outcomes of treatment Assessment of effectiveness and cost effectiveness

3. Proposed Methods: Migrants in Italy (WP 5) New migrants arriving in Sicily: Active TB Screening – combining symptoms and Xpert Migrants settling in Italy: latent TB test with 4 th generation Quantiferon test All recruited individuals to complete demographic questionnaire and clinical data collected Assessment of effectiveness and cost effective of screening

3. Proposed Methods: Latent TB (WP 6) Establish latent TB data pooling protocol and agreement Develop latent TB database Pool data from Netherlands, Italy, UK and Sweden Invite others to join Analysis of yield and predictive value of latent TB testing Analysis by sub-group e.g. HIV

3. Methods: WP 7 10 TB strategy prioritisation & support plan Consensus and recommendations Expert meeting SurveyPolicy review

3. Methods: WP7 Survey Survey of national TB strategies and action plans Addressed to programme leads across EU/EEA Building on available information Facility to upload policy documents for review Aim is to get good overview of plans, including objectives, content, coverage, recommendations and implementation, including any barriers To overview of policies and recommendations, barriers to implementation and allow gap analysis across Europe Results of the survey to fed back to programme leads and discussed at the expert meeting 11

3. Methods: WP 7 Policy review/expert meeting Systematic review Systematic review of relevant policies and recommendations Summarising current policies and “best practice” for recommendations and strategy components and potential gaps Results of the policy review to be fed back to programme leads and discussed at the expert meeting Expert Meeting Invitation to national programme leads and other TB experts Views will be sought and consensus built iteratively on key questions posed to experts (Delphi methodology) 12

3 Methods: WP7 TB strategy prioritisation, action and support plan Using information from the survey, policy review and expert meeting A practical step by step document based on expert recommendations Suggesting/ recommending for TB strategies and policies Who needs to be involved? What should be the content? What is best practice? What are the implementation steps? How to overcome common barriers? Stakeholder presentation Road testing 13

4. Expected outcomes Outreach activity in Romania and Bulgaria is expected to lead to the early detection of active TB. –Detection of active TB using MXU in Romania and Bulgaria: –Treatment of detected patients in Romania and Bulgaria Implement and evaluate migrant TB detection in Italy and early diagnosis of active and latent TB in migrants in low incidence countries. –Number of latent and active TB cases detected among temporary migrants in Italy –Linkage to care among detected migrants in Italy Creating a database listing active and latent TB cases, in migrants from low incidence countries. –Multi country data platforms for latent TB established Strengthening national TB programmes –Improved understanding of differences and commonalities of TB strategies and action plans across the EU/EEA –A TB strategy prioritisation, action and support plan for countries to develop and implement evidence based TB action plans and strategies.

5. Tools planned Questionnaires: –WP 4: mobile screening data collection, supported referral and clinical outcome data collection –WP 5: Data collection tools for latent and active TB Databases: –WP 4: digital x-ray, screening data, clinical data, microbiology results, outcome data –WP 5: Latent TB database, Active TB screening database –WP 6: Latent TB database Trainings: –WP4: MXU training, WP 5: screening training, WP 2: overall dissemination training package Reports and Survey –Interim and final reports, evaluation report, country specific reports, peer reviewed papers from each WP –Survey in WP 7

6. Partnerships University College London (UCL)UK KNCV Tuberculosis Foundation (KNCV)Netherlands Ospedale San Raffaele (OSR)Italy National de Pneumoftiziologie Prof. Dr. Marius Nasta-National TB Programme (NTPR) Romania Karolinska Institute (KI)Sweden Universita degli Studi di Brescia (UNIBS)Italy Public Health England (PHE)UK Delft imaging systems (DELFT)Netherlands Folkhälsomyndigheten-Public Health Agency Sweden (FoHM)Sweden INMI Spallanzani, Rome (INMI)Italy Health Strategies Programme Centre-National TB Programme (HSPC)Bulgaria

6. Partnerships: Countries

Acknowledgement 18